Literature DB >> 2319462

Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome.

K A Kirchner1, J R Voelker, D C Brater.   

Abstract

An attenuated response to loop diuretics is a frequent observation in the nephrotic syndrome. To determine if the presence of albumin in renal tubular fluid attenuates diuretic response in normal rats, in vivo loop segment microperfusion was performed in normal rats at 20 nl/min with perfusates containing 6.0 microM furosemide in the presence and absence of 3.8 microM albumin. Compared to loop segments perfused without diuretic (control), furosemide reduced (P less than .001) fractional chloride uptake from 56 +/- 2 to 34 +/- 2%. After addition of albumin to furosemide perfusate, fractional loop chloride reabsorption was 45 +/- 1%; a value greater (P less than .01) than that observed in furosemide perfused loop segments, but less (P less than .05) than that observed in control loop segments. Albumin added to perfusate in the absence of furosemide had no effect on fractional loop segment chloride uptake. Addition of 1.7 microM immunoglobulin G to furosemide perfusate failed to attenuate furosemide response. Absolute loop segment chloride reabsorption demonstrated a similar pattern. Tubule fluid perfusion rates determined in vivo and loop segment fluid reabsorption were equivalent in all groups. Thus, albumin in renal tubule fluid attenuates the effect of furosemide on loop segment chloride reabsorption in the rat. This blunted response presumably occurs because of a reduction in the amount of pharmacologically active drug due to albumin-furosemide binding. Consequently, albumin-furosemide binding in the renal tubule may contribute to the diuretic resistance in nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2319462

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Management of Cardio-Renal Syndrome and Diuretic Resistance.

Authors:  Frederik H Verbrugge; Wilfried Mullens; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

Review 2.  Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.

Authors:  D A Sica; T W Gehr
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

Review 3.  Treatment of Disorders of Sodium Balance in Chronic Kidney Disease.

Authors:  David H Ellison
Journal:  Adv Chronic Kidney Dis       Date:  2017-09       Impact factor: 3.620

Review 4.  Loop diuretic resistance complicating acute heart failure.

Authors:  Zachary L Cox; Jeffrey M Testani
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

5.  Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin?

Authors:  F Akcicek; T Yalniz; A Basci; E Ok; E J Mees
Journal:  BMJ       Date:  1995-01-21

6.  Serum and Urine Albumin and Response to Loop Diuretics in Heart Failure.

Authors:  Antonios Charokopos; Matthew Griffin; Veena S Rao; Lesley Inker; Krishna Sury; Jennifer Asher; Jeffrey Turner; Devin Mahoney; Zachary L Cox; F Perry Wilson; Jeffrey M Testani
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-22       Impact factor: 8.237

7.  Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study.

Authors:  Gaurav Kapur; Rudolph P Valentini; Abubakr A Imam; Tej K Mattoo
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

8.  Pathobiology of cast nephropathy from human Bence Jones proteins.

Authors:  P W Sanders; B B Booker
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

Review 9.  Diuretic strategies in patients with renal failure.

Authors:  S K Swan
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

10.  The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study.

Authors:  Bunyong Phakdeekitcharoen; Kochawan Boonyawat
Journal:  BMC Nephrol       Date:  2012-08-29       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.